Brain Tumor News!
Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
11/06/01
NeoPharm Announces Third Quarter 2001 Financial Results and Declares 10% Stock Dividend
(Business Wire)
...Two of the compounds under development use the Company's
tumor-targeting platform to target
tumor cells and deliver the potent cytotoxic agent,......
tumor-targeting platform to target
tumor cells and deliver the potent cytotoxic agent, PE38, to destroy
tumors.......IL13-PE38 uses the IL13 protein to target receptors on
brain and kidney tumors, while SS1-...
11/06/01
New Device at Stanford Delivers Safer, Targeted Brain Tumor Treatment
(Business Wire)
A Stanford University Medical Center neurosurgeon is one of the first in the country to treat
brain tumors with a new device for delivering aggressive intratumoral radiation -- radiation therapy that irradiates cancerous cells from within the
tumor cavity.
11/06/01
Allos Drug Boosts Lung Cancer Survival, Study Says
(Reuters)
...Increasing oxygenation of
tumors, which often have disorganized blood supplies, makes them more susceptible to cancer-killing......Allos is also conducting clinical trial of RSR13 in metastatic
brain tumors and primary
brain cancer. ...
11/06/01
Allos drug boosts lung cancer survival - study
(Reuters Securities)
...Increasing oxygenation of
tumors, which often have disorganized blood supplies, makes them more susceptible to cancer-killing......Allos is also conducting clinical trial of RSR13 in metastatic
brain tumors and primary
brain cancer....
11/02/01
Pharmacyclics Announces Six Xcytrin Abstracts to Be Presented at ASTRO Annual Meeting Next Week
(PR Newswire)
... company's pivotal 429-patient Phase III clinical trial of Xcytrin for the potential treatment of
brain metastases.......That study will report on the strong correlation between
tumor size and neurocognitive function, further validating one of the study's two co-primary endpoints....... highlight Xcytrin's potential utility in glioblastoma multiforme (i.e., GBM or primary
brain tumors) and further elucidate Xcytrin's unique mechanism of action....
11/01/01
SF Nurse Wins Nation's Highest Caregiving Honor
(PR Newswire)
... than 3,200 men and women have attended the Center's FREE classes focused on HIV/AIDS, cancer,
brain tumors, heart disease, lung disease, and care for frail elders....
11/01/01
Panacea Pharmaceuticals, Inc. Presents New Findings on HAAH Oncology Program At AACR-NCI-EORTC International Conference
(PR Newswire)
...HAAH over-expression has been detected in primary
tumor tissue of all eighteen
tumor types tested to date, including cancers of the pancreas,...... including cancers of the pancreas, breast, ovary, liver, colon, prostate, lung,
brain, and bile duct....... all animals that received injections of cells expressing high levels of HAAH developed
tumors at the injection site....
11/01/01
Pharmacyclics Reports First Quarter Results
(PR Newswire)
... Phase III clinical trial of Xcytrin® (motexafin gadolinium) Injection for the treatment of
brain metastases....... company's Xcytrin Phase II clinical trial for treatment of glioblastoma multiforme (primary
brain tumor)....
11/01/01
Cancer-Linked Gene Also Controls Stem Cells: Study
(Reuters)
A gene that helps suppress
tumors also controls the proliferation of stem cells in the
brains of mice, scientists have found. They say the discovery could help them better understand--and possibly treat--aggressive
tumors of the
brain and other types of cancer in humans.
